Clinical trial
Combination Chemotherapy in Treating Men With Germ Cell Cancer
NCT00003643 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status
Key facts
| NCT number | NCT00003643 |
|---|---|
| Title | Combination Chemotherapy in Treating Men With Germ Cell Cancer |
| Official title | Randomized Phase II/III Study of Taxol/Paclitaxel-BEP Versus BEP in Patients With Intermediate Prognosis Germ Cell Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, filgrastim, cisplatin, etoposide, paclitaxel |
| Enrollment | 498 |
| Start date | Oct 1, 1998 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 6, 2012 |
| Countries | Austria, Belgium, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Slovakia and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: